Affimed NV (AFMD)
2.64
-0.08
(-2.94%)
USD |
NASDAQ |
Nov 21, 16:00
2.67
+0.03
(+1.14%)
After-Hours: 20:00
Affimed Total Liabilities (Quarterly): 25.43M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 25.43M |
| June 30, 2024 | 26.22M |
| March 31, 2024 | 32.28M |
| December 31, 2023 | 43.50M |
| September 30, 2023 | 46.62M |
| June 30, 2023 | 38.89M |
| March 31, 2023 | 46.74M |
| December 31, 2022 | 51.04M |
| September 30, 2022 | 54.35M |
| June 30, 2022 | 71.12M |
| March 31, 2022 | 84.64M |
| December 31, 2021 | 100.98M |
| September 30, 2021 | 100.31M |
| June 30, 2021 | 115.60M |
| March 31, 2021 | 119.28M |
| December 31, 2020 | 127.59M |
| September 30, 2020 | 71.53M |
| June 30, 2020 | 68.21M |
| March 31, 2020 | 72.61M |
| December 31, 2019 | 82.55M |
| September 30, 2019 | 69.28M |
| June 30, 2019 | 75.35M |
| Date | Value |
|---|---|
| March 31, 2019 | 76.01M |
| December 31, 2018 | 86.99M |
| September 30, 2018 | 15.36M |
| June 30, 2018 | 14.26M |
| March 31, 2018 | 15.20M |
| December 31, 2017 | 13.89M |
| September 30, 2017 | 13.61M |
| June 30, 2017 | 14.97M |
| March 31, 2017 | 10.10M |
| December 31, 2016 | 10.56M |
| September 30, 2016 | 11.26M |
| June 30, 2016 | 10.10M |
| March 31, 2016 | 12.29M |
| December 31, 2015 | 13.17M |
| September 30, 2015 | 10.59M |
| June 30, 2015 | 10.62M |
| March 31, 2015 | 9.353M |
| December 31, 2014 | 12.30M |
| September 30, 2014 | 12.79M |
| June 30, 2014 | 144.65M |
| March 31, 2014 | 167.67M |
| December 31, 2013 | 145.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.43M
Minimum
Sep 2024
127.59M
Maximum
Dec 2020
68.97M
Average
69.66M
Median
Total Liabilities (Quarterly) Benchmarks
| InflaRx NV | 16.09M |
| BioNTech SE | 3.671B |
| Immatics NV | 217.47M |
| CureVac NV | 144.63M |
| ATAI Life Sciences NV | 51.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.63M |
| Shareholders Equity (Quarterly) | 19.21M |
| Debt to Equity Ratio | 0.469 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | 2.62% |